Studying the incremental role of frailty in predicting in-hospital, short-term (30 days), and mid-term (6 months) bleeding in ACS patients.

Potent platelet inhibition reduces the risk of thrombotic complications in patients with acute coronary syndromes. Unavoidably, the more potent platelet inhibition increases the risk of bleeding. Bleeding risk can be predicted using the ARC-HBR criteria, the CRUSADE score, ACUITY score, and PRECISE-DAPT score. These conventional risk scores incorporate clinical, laboratory and procedural variables but often overlook patient centered geriatric parameters such as frailty. Frailty is a multidimensional syndrome characterized by decreased reserves and diminished resistance to stressors. It can be assessed using Rockwoods clinical frailty scale, the frailty index, frailty domains and the Fried scale. The association between frailty and bleeding risk in ACS patients is still inadequately studied. We hypothesize that frailty indices would increase the discriminatory power of established standard bleeding risk scores, and would predict bleeding events among ACS patients.

Inclusion Criteria:

1. - Patients must be suffering from acute coronary syndrome ( STEMI - NSTEMI ) at the time of recruitment
2. - Patients must be older than 65 years

Exclusion Criteria:

1. - Patients younger than 65 years
2. - Refusal of participation
3. - In - hospital death unrelated to bleeding

Patients presenting with acute coronary syndrome ( STEMI and NSTEMI) and are older than 65 years